Clinical Trial Update: A Pilot Study Comparing Tolerance of Oral Heme Iron Polypeptide With Oral Ionic Iron [Phase 4]

View source ↗

Summary

A Phase 4 pilot trial comparing tolerance of oral heme iron polypeptide versus oral ionic iron for iron deficiency was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Deficiency Anemia

Drugs mentioned

• Oral heme iron polypeptide (heme iron polypeptide)
• Oral ionic iron (ionic iron)

Snippet

Sponsor: Milton S. Hershey Medical Center | Conditions: Iron Deficiency | Phase 4 | Status: WITHDRAWN